These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 19670319

  • 21. Nephrotic syndrome in a patient with relapsed of chronic myeloid leukemia after peripheral blood stem cell transplantation.
    Bee PC, Gan GG, Sangkar VJ, Haris AR.
    Med J Malaysia; 2008 Mar; 63(1):71-2. PubMed ID: 18935742
    [Abstract] [Full Text] [Related]

  • 22. Donor leukocyte infusions and graft-versus-malignancy.
    Antin JH.
    J Clin Apher; 2005 Jul; 20(2):113-6. PubMed ID: 15880356
    [No Abstract] [Full Text] [Related]

  • 23. Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis.
    Nyberg P, Wikman AL, Nennesmo I, Lundberg I.
    J Rheumatol; 2000 Apr; 27(4):940-8. PubMed ID: 10782820
    [Abstract] [Full Text] [Related]

  • 24. Isolated acral dermatitis due to graft-versus-host disease.
    van der Velden W, Lesterhuis J, Blokx W, Schattenberg A.
    Eur J Haematol; 2009 Apr; 82(4):326. PubMed ID: 19077047
    [No Abstract] [Full Text] [Related]

  • 25. Ocular involvement in chronic graft-versus-host disease: therapeutic approaches to complicated courses.
    Koch KR, Joussen AM, Huber KK.
    Cornea; 2011 Jan; 30(1):107-13. PubMed ID: 20847653
    [Abstract] [Full Text] [Related]

  • 26. Very late appearance of acute graft-versus-host disease after tapering immunosuppression.
    Wollina U, Sayer HG, Wollina K, Graefe T.
    J Dermatol; 2001 Dec; 28(12):734-6. PubMed ID: 11804070
    [Abstract] [Full Text] [Related]

  • 27. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease.
    Marra DE, McKee PH, Nghiem P.
    J Am Acad Dermatol; 2004 Oct; 51(4):543-6. PubMed ID: 15389188
    [Abstract] [Full Text] [Related]

  • 28. Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus.
    Schmook T, Kraft J, Benninghoff B, Nindl I, Roewert J, Ulrich C, Stockfleth E.
    Bone Marrow Transplant; 2005 Jul; 36(1):87-8. PubMed ID: 15895116
    [No Abstract] [Full Text] [Related]

  • 29. Management of chronic graft-versus-host disease.
    Baker M, McKiernan P.
    Clin J Oncol Nurs; 2011 Aug; 15(4):429-32. PubMed ID: 21810577
    [Abstract] [Full Text] [Related]

  • 30. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Chiang CC, Lin JM, Chen WL, Tsai YY.
    Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623
    [Abstract] [Full Text] [Related]

  • 31. Catastrophic antiphospholipid syndrome: atypical presentation in the setting of chronic graft versus host disease: case report and review of the literature.
    Kasamon KM, Drachenberg CI, Rapoport AP, Badros A.
    Haematologica; 2005 Mar; 90(3):ECR17. PubMed ID: 15753058
    [Abstract] [Full Text] [Related]

  • 32. Serum muscle enzymes, muscle pathology and clinical muscle weakness: correlation in Thai patients with polymyositis/dermatomyositis.
    Louthrenoo W, Weerayutwattana N, Lertprasertsuke N, Sukitawut W.
    J Med Assoc Thai; 2002 Jan; 85(1):26-32. PubMed ID: 12075717
    [Abstract] [Full Text] [Related]

  • 33. Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.
    Moreno-Romero JA, Fernández-Avilés F, Carreras E, Rovira M, Martínez C, Mascaró JM.
    Arch Dermatol; 2008 Sep; 144(9):1106-9. PubMed ID: 18794453
    [No Abstract] [Full Text] [Related]

  • 34. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
    Hammond SP, Borchelt AM, Ukomadu C, Ho VT, Baden LR, Marty FM.
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1049-59. PubMed ID: 19660717
    [Abstract] [Full Text] [Related]

  • 35. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients.
    Miles L, Bove KE, Lovell D, Wargula JC, Bukulmez H, Shao M, Salisbury S, Bean JA.
    Arthritis Rheum; 2007 Oct 15; 57(7):1183-91. PubMed ID: 17907236
    [Abstract] [Full Text] [Related]

  • 36. Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft-versus-host disease.
    Bolaños-Meade J, Zhou L, Hoke A, Corse A, Vogelsang G, Wagner KR.
    Am J Hematol; 2005 Apr 15; 78(4):306-9. PubMed ID: 15795921
    [Abstract] [Full Text] [Related]

  • 37. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I, Porcher R, Robin M, de Latour RP, Glotz D, Socié G, Peraldi MN.
    Biol Blood Marrow Transplant; 2009 Oct 15; 15(10):1251-7. PubMed ID: 19747632
    [Abstract] [Full Text] [Related]

  • 38. Clonal expansion of limited T cell clonotypes in affected muscle from a patient with post-transplant polymyositis.
    Kojima K, Kurokawa MS, Tanimoto K, Kojima Y, Hara M, Yoshino T, Harada M, Tanimoto M, Nishioka K, Kato T.
    Bone Marrow Transplant; 2002 Oct 15; 30(7):467-70. PubMed ID: 12368961
    [Abstract] [Full Text] [Related]

  • 39. Vitiligo after hematopoietic cell transplantation: six cases and review of the literature.
    Sanli H, Akay BN, Arat M, Koçyigit P, Akan H, Beksac M, Ilhan O.
    Dermatology; 2008 Oct 15; 216(4):349-54. PubMed ID: 18285686
    [Abstract] [Full Text] [Related]

  • 40. Laryngeal stenosis associated with chronic graft-versus-host disease following unrelated bone marrow transplantation.
    Hirokawa M, Kume M, Wu T, Ishikawa K, Sawada KI.
    Bone Marrow Transplant; 2006 Sep 15; 38(5):387-8. PubMed ID: 16862163
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.